Patient Advocate since 1977.

Leave a comment

Canadian pot companies see medical exports growing under Trudeau law


By Josh Wingrove and Jen Skerritt, Bloomberg News

OTTAWA, Canada — Canada’s push to legalize recreational marijuana is rippling beyond its borders as companies move to boost exports of medicinal pot.

Prime Minister Justin Trudeau’s government unveiled its framework last week, quelling concern it would clamp down on export permits for existing medical-pot producers such as Canopy Growth Corp. and Aurora Cannabis Inc. Those companies, which have a head start on the legal recreational market, will continue to be allowed to export marijuana to countries such as Germany and Australia for medical and scientific use.

“It might not be so limited,” said Emily Larose, a partner with law firm Cassels Brock who specializes in cannabis regulation. Industry fears of onerous export restrictions have receded over the past year as bureaucrats typically approve any permit so long as the main requirements are met. “The way in which they’ve been granted so far seems to be more box-ticking.”

Companies in Canada, the second country and first major economy to unveil plans for legalization of recreational pot, have already secured investments and partnerships in countries where support for legalized medical marijuana is gaining ground. The global cannabis market may be worth $200 billion, with the medical market accounting for 25 percent to 50 percent of that, Daniel Pearlstein, a research analyst in Toronto at Eight Capital, said by email.

Canopy is already exporting to Brazil and Germany. Last year, the Smith Falls, Ontario-based company acquired pharmaceutical distributor MedCann GmbH, which has placed its cannabis strains in German pharmacies.

Bedrocan Canada Inc., a unit of Canopy, exported 10 kilograms of dried cannabis to Brazil to be used in a clinical study targeting epilepsy and pain management, according to a November statement.

Canada is emerging as a leader in public policy around marijuana and other countries will need its know-how as they shift toward making cannabis and cannabinoids part of standard medical treatment, said Chief Executive Officer Bruce Linton. That gives Canopy the chance to export product while the domestic industry makes that transition, and to set up production on the ground once it has, he said.

“All of these jurisdictions are contemplating or structuring a way in which production will occur in them,” Linton said by phone. “We are actually an exporter of public policy.”

That meshes with Trudeau’s view for the future of the Canadian economy: one pivoting from raw resource extraction toward white-collar jobs in the services sector.

“You’re going to develop know-how on how to make this stuff,” said Eileen McMahon, a partner at Torys LLP and chair of the law firm’s intellectual property and food and drug regulatory practices. “That know-how arguably could be used” outside Canada under the Trudeau law, she said, adding it’s possible “employees with that expertise could cross the border.”

Aurora intends to be a “significant” player in the Australian market and is looking at others as well, said Cam Battley, an executive vice president. The Cremona, Alberta-based company plans to use its capital and experience to export its product, and to set up in countries where marijuana may soon be legal, he said.

“Canada more broadly is a leader in the cannabis industry,” Battley said by phone. “That gives us a lot of potential power in other markets.”

Exports will be allowed “as long as they meet the strict regulatory requirements,” lawmaker Bill Blair, a former police chief and Trudeau’s point man on pot legalization, said in an interview. He brushed aside questions about whether the government wants to encourage companies to be exporters. “We want to make sure there is a viable industry capable of supplying that well-regulated retail market” domestically in Canada.

The government has to issue export permits repeatedly, and could clamp down, change guidelines or slow its issuing of permits if it wanted to cool the market.

In a notice posted last year, Canada said it “does not support facilitating a regime premised on servicing global demand given the associated public health, safety and security risks” and that export “would be permitted under very limited circumstances.” Fears stoked in industry by that notice have since eased, Larose said.

Aurora secured a 19.9 percent stake last month in Cann Group, the first Australian company to be licensed for research and cultivation of medical cannabis for human use.

Aphria Inc., based in Leamington, Ontario, is investing $25 million in a dispensing operation in Florida, the company said April 4. Aphria’s U.S. expansion strategy is to target key states that have approved medical marijuana, according to the statement.

Canada’s legalization effort may violate its obligations under international law, Steven Hoffman, director of the University of Ottawa’s Global Strategy Lab, wrote in a Globe and Mail editorial this week. “Unless we change our constitution, Canada cannot legally legalize cannabis without either renegotiating the U.N. treaties, obtaining special exceptions, finding creative workarounds, or withdrawing from them,” he wrote.

The government believes its restrictions on production or sale outside its strictly regulated regime, as well as restrictions on some exports and use by minors, keeps it onside, Blair said.

“We believe this enables us to uphold and maintain our obligations under those treaties,” he said, speaking in an interview after Justice Minister Jody Wilson-Raybould referred questions on the matter to Blair.

Leave a comment

Germany Medical Marijuana / Cannabis Application to Grow – German partner wanted – for Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte 2017/S 070-131987

If you a German organization interested in partnering with one of the world’s leading producers of pharmaceutical grade cannabis, please send a confidential email to phil@cenedella.de  for immediate consideration as a strategic and financial partner in the German BfArM application titled:

Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte

2017/S 070-131987


1 Comment

BERLIN PEACE ACCORDS – “putting an end to the world war on Cannabis!”

April 20th NEWS ALERT:

The BERLIN PEACE ACCORDS, “putting an end to the world war on Cannabis” were ratified last week and are now available for your signature at http://www.berlinpeaceaccords.de

This is your chance to add your name to this historic document and tell the Presidents of the United States, the United Nations, the European Union as well as Chancellor Merkel of Germany that the world war on Cannabis needs to end in 2017.

Please sign petition at http://www.berlinpeaceaccords.com and share with others so inclined.
Thank you, Gracias und Dankeschoene!


We the people of the Year 2017 do…
Hereby declare that it is our inalienable basic human right to have the freedom to grow, medicate and enjoy the plant we call Cannabis, without any governmental limitations.
We demand our plant has no more regulations or limitations than a tomato plant.
It is our basic human right to have control of what we choose to put into our body.
It is our basic human right to have the ability to enjoy this plant without fear of incarceration or limitations on its commerce.
It is our basic human right to have multiple ways to enjoy, grow and medicate with our plant and we demand that no commercial organization be provided exclusive use or rights.
For 10,000 years humans on our planet have enjoyed the benefits provided by our plant. With my signature below I do hereby attest it is my wish that “we the people” have the right to consume our plant as we wish.
Wir, die Menschheit des Jahres 2017…
Erklären hiermit unser unveräußerliches Menschenrecht auf Anbau, Medikation und Konsum der Pflanze mit dem Namen Cannabis ohne jegliche staatliche Einschränkung. Verlangen, dass unsere Pflanze keine anderen Auflagen und
Einschränkungen als eine Tomatenpflanze hat. Stellen unter unsere eigene Kontrolle, was wir unserem Körper zuführen. Bestehen auf unser Grundrecht, diese Pflanze zu benutzen ohne die Androhung von Freiheitsberaubung und ohne Nutzungsbeschränkungen.
Es ist unser Grundrecht, auf verschiedenste Arten Zugang zu Cannabis zu haben und keine kommerziellen Interessenverbände das Recht auf exklusive Nutzung oder Rechtsanspruch erhalten. Seit Urzeiten haben die Menschen die Segnungen unserer Pflanze genutzt.
Mit meiner Unterschrift lege ich hiermit Zeugnis ab über meinem Wunsch, dass „wir, die Menschen“ das Recht besitzen, unsere Pflanze nach unseren Wünschen zu benutzen.

1 Comment

BERLIN PEACE ACCORDS – putting an end to the world war on Cannabis.


12 April 2017

Berlin, Germany


On the closing day of the International Cannabis Business Conference in Berlin, advocates from throughout the world ratified the BERLIN PEACE ACCORDS that call for an immediate end to the world war on cannabis.

On July 7, 2017 these Accords will be presented to President Donald Trump of the United States and Chancellor Angela Merkel of Germany at their summit meeting in Hamburg, Germany. In advance of that date, advocates worldwide will be showing their support by simply “liking” it on the facebook page: https://www.facebook.com/Berlin-PEACE-Accords-1899471536976478/

Citizens of the world who are in support of the BERLIN PEACE ACCORDS are urged to print these Accords off, sign them, place them at your home or office, and share them with others.

In addition, advocates will be re-posting these Accords on their respective facebook pages (and other social media) to have their members, customers, colleagues “like” the Accords as well.

If you are interested in becoming a “link on the chain” to peace or have any questions, please feel free to contact phil@cenedella.de for additional information or to support our efforts in anyway.

President Trump and Chancellor Merkel are interested to know if people in the year 2017 really feel this way.

Now is the time for you to show you do.


The Advocates of the


We the people of the Year 2017 do…

Hereby declare that it is our inalienable basic human right to have the freedom to grow, medicate and enjoy the plant we call Cannabis, without any governmental limitations.

We demand our plant has no more regulations or limitations than a tomato plant.
It is our basic human right to have control of what we choose to put into our body.

It is our basic human right to have the ability to enjoy this plant without fear of incarceration or limitations on its commerce.

It is our basic human right to have multiple ways to enjoy, grow and medicate with our plant and we demand that no commercial organization be provided exclusive use or rights.
For 10,000 years humans on our planet have enjoyed the benefits provided by our plant. With my signature below I do hereby attest it is my wish that “we the people” have the right to consume our plant as we wish.


Thank you, Gracias und Dankeschoene,

1 Comment

BERLIN PEACE ACCORDS – “putting a just end to the world war on Cannabis!”

Philip J. Cenedella IV
27 March 2017
Berlin, Germany

BERLIN  PEACE  ACCORDS  “putting a just end to the world war on Cannabis!”

(The Berlin Peace Accords to be signed at the ICBC-Berlin Conference on April 12, 2017)

On April 10-12, 2017 hundreds of international leaders in the Cannabis Industry will be assembling in Berlin for what many are calling the most significant and historic cannabis conference in Europe ever –  The International Cannabis Business Conference www.internationalcbc.com

The BERLIN  PEACE  ACCORDS  “putting a just end to the world war on Cannabis!” will be officially introduced to the media and all attendees at a press conference to be held on April 12th.  In advance of President Trump and Chancellor Merkel’s meeting in Hamburg, Germany this July, cannabis advocates have constructed a document calling on those national leaders, and all governments worldwide, to immediately coordinate their efforts and put an end to the campaign of intolerance and incarceration.  Quantum 9,  Cenedella.de and many others will be signing the BERLIN PEACE ACCORDS and presenting it directly to Senator Rohrabacher of the U.S. Congress for action.  We invite Industry professionals to contact us to be involved even if you are unable to attend in person.

So what is happening in Germany today and how will it impact you and your company?

Good questions, with multiple answers, but it really comes down to the fact that Germany has now implemented a comprehensive medical marijuana distribution program with the March 9th registration of the “Cannabis as Medicine” Act <Bundesgesetzblatt Teil I 2017 Nr. 11>   This is a historic moment in our movement for the regulation, legalization, social acceptance of our plant and we commend the advocates on the frontlines of this decades-long fight, most notably Mr. George Wurth of the Hemp Association and a Speaker at ICBC Berlin.  The ICBC Berlin event could not be happening in a better location nor be any more timely.  We salute Alex Rogers and his incredibly professional team for having the foresight to make this event happen and we welcome everyone in the industry to join us in Berlin from April 10-12th!

With over twice the population of California in half the space, Germany is key to the formation of a legal, reliable and professional Cannabis industry within the entire European Union.  The Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM) in Bonn is a government organization and your central point of contact for all things Cannabis.  Currently the German government imports all medicine for patients exclusively from Canada and the Netherlands, with the stated goal of developing a robust, and pharmaceutical-grade grow industry within its own borders by 2019.

Pharmacies in Germany are managed by the State Office of Health and Social Affairs and are going to be the only distribution point for pre-approved medical marijuana products.  The Pharmacy situation here is really quite different than in America with medically-trained staff at thousands of locations only now learning of how to implement this new law and serve their patients effectively.   There are numerous opportunities for companies, consultants and organizations to help fill the void with a recent estimate calculating the need for over 500,000 lbs. of pharmaceutical-grade medical marijuana needed per year.

The medical and therapeutic uses of cannabis are extremely important but the calls for recreational implementation is also at the top of the agenda for many.  During the past few years a few German cities have started the process of establishing a German recreational marketplace and although Berlin has been stymied in its efforts to date, the upcoming national elections may have a positive impact on those efforts.  The City of Dusseldorf has a pilot project to sell recreational cannabis to adults slated to start this summer and other German cities are working on similar measures at the behest of their citizens.   Germany is indeed central to the success of a legal, professional and workable European cannabis marketplace.  Countries that will also have a significant impact on the future of the EU industry include:  Canada, Netherlands, Switzerland, Albania, Spain, United Kingdom, Israel and the USA.

We invite you to ICBC Berlin on April 10-12th at the Maritim ProArte Hotel Berlin.  Stop by our tabletop and note that for all attendees we will providing free phone calls to the USA, free wifi, and free electric plug-in for all those that forget their European adapters J   Any comments or questions on this post are welcomed by contacting me directly at  phil@cenedella.de , +1.888.206.3264 or via skype at  philip.j.cenedella.


Thank you, Dank je, Gracias, and Danke schoene,

  • Phil

1 Comment

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis”

Von: Philip J. Cenedella IV


31. März 2017 Berlin, Deutschland

BERLIN PEACE ACCORDS “ein Ende des Weltkriegs gegen Cannabis” (Das Berliner Friedensabkommen wird auf der ICBC-Berlin-Konferenz am 12. April 2017 unterzeichnet)

Am 10.-12. April 2017 werden Hunderte von internationalen Führungskräften in der Cannabis-Industrie in Berlin zusammenarbeiten. Viele nennen sie die bedeutendste und historischste Cannabis- Konferenz in Europa: die Internationale Cannabis-Business-Konferenz kurz ICBC, http://www.internationalcbc.com

Die BERLIN PEACE ACCORDS, die dem Weltkrieg gegen Cannabis ein Ende setzen möchten, werden offiziell den Medien und allen Teilnehmer*innen auf einer Pressekonferenz, die am 12. April stattfinden wird, vorgestellt. Im Vorfeld vom Treffen zwischen Präsident Trump und Bundeskanzlerin Merkel in Hamburg, Deutschland im Juli 2017, haben Cannabis-Befürworter*innen ein Dokument erstellt, dass die nationalen Führer*innen und alle Regierungen weltweit adressiert, um ihre Bemühungen sofort zu koordinieren und die Kampagne der Intoleranz und der Inhaftierung zu beenden. Quantum 9, Cenedella.de und viele andere unterzeichnen die BERLIN PEACE ACCORDS und präsentieren sie direkt an Senator Rohrabacher vom U.S. Kongress zum Handeln.

Wir laden Fachleute der Industrie ein, mit uns in Kontakt zu treten, auch wenn Sie nicht persönlich teilnehmen können.

Was geschieht heute in Deutschland und wie wird es Sie und Ihr Unternehmen beeinflussen?

Gute Fragen, mit vielfältigen Antworten, aber es kommt wirklich darauf an, dass Deutschland nun mit dem 9. März ein umfangreiches medizinisches Marihuana-Verteilungsprogramm umgesetzt hat: das neue Gesetz “Cannabis als Medizin” Dies ist ein historischer Moment in unserer Bewegung für die Regulierung, die Legalisierung, die soziale Akzeptanz unserer Pflanze. Wir loben all die Verfechter*innen an den Frontlinien dieses jahrzehntelangen Kampfes, insbesondere Herrn George Wurth von der Hanf-Vereinigung, der auch als Referent an der ICBC Berlin beteiligt sein wird.

Die ICBC-Berlin-Veranstaltung hätte nicht besser lokalisiert noch terminiert werden können. Wir bedanken uns bei Alex Rogers und sein unglaublich professionelles Team für die Voraussicht, um dieses Event zu initiieren und wir laden alle in der Branche herzlich ein, uns vom 10. bis 12. April in Berlin zu besuchen! Mit mehr als doppelt soviel Einwohner*innen wie Kalifornien, aber in der Hälfte des Raumes, ist Deutschland der Schlüssel zur Bildung einer legalen, zuverlässigen und professionellen Cannabis-Industrie innerhalb der gesamten Europäischen Union. Das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) in Bonn ist eine Regierungsorganisation und ihr zentraler Ansprechpartner zur Thematik Cannabis. Derzeit importiert die Bundesregierung alle Medikamente für Patient*innen ausschließlich aus Kanada und den Niederlanden. Das erklärte Ziel ist eine robuste und pharmazeutische Anbau- Industrie innerhalb der eigenen Grenzen bis 2019 zu entwickeln.

Apotheken in Deutschland werden vom Staatlichen Amt für Gesundheit und Soziales betreut und sind der einzige Verteilungspunkt für vorab genehmigte medizinische Marihuana-Produkte. Die Apotheken-Situation ist wirklich ganz anders als in Amerika, mit medizinisch ausgebildeten Mitarbeiter*innen an Tausenden von Standorten. Jetzt gilt es zu lernen, wie man dieses neue Gesetz umsetzen und ihre Patient*innen effektiv bedienen soll. Es gibt zahlreiche Möglichkeiten für Unternehmen, Berater*innen und Organisationen zu helfen, die Leere, die aktuell geschätzte Notwendigkeit von über 500.000 Pfund des benötigten medizinischen Marihuanas pro Jahr zu füllen.

Die medizinische und therapeutische Verwendung von Cannabis ist äußerst wichtig, aber die Aufforderungen zur Freizeitgestaltung stehen auch für viele an der Spitze der Agenda. In den vergangenen Jahren haben ein paar deutsche Städte den Prozess der Gründung eines deutschen Marktes begonnen, und obwohl Berlin in seinen bisherigen Bemühungen gehindert wurde, können sich die bevorstehenden nationalen Wahlen positiv auf diese Bemühungen auswirken. Die Stadt Düsseldorf beispielsweise, hat ein Pilotprojekt, um Freizeit-Cannabis an Erwachsene zu verkaufen und andere deutsche Städte arbeiten an ähnlichen Maßnahmen auf Zuspruch ihrer Bürger*innen.

Deutschland ist in der Tat zentral für den Erfolg eines legalen, professionellen und praktikablen europäischen Cannabismarktes. Länder, die auch einen bedeutenden Einfluss auf die Zukunft der EU-Industrie haben, sind: Kanada, Niederlande, Schweiz, Albanien, Spanien, Großbritannien, Israel und die USA.

Wir laden Sie zur ICBC Berlin am 10.-12. April im Maritim ProArte Hotel Berlin ein. Stoppen Sie an unserem Stand und beachten Sie, dass wir für alle Teilnehmer*innen kostenlose Telefonate in die USA, kostenloses WiFi und kostenloses Plug-in, für alle, die ihre europäischen Adapter vergessen haben, zur Verfügung stellen. 🙂 Alle Kommentare oder Fragen zu diesem Beitrag werden begrüßt, indem Sie mich kontaktieren direkt unter phil@cenedella.de, +1.888.206.3264 oder über skype unter philip.j.cenedella. Danke, Dank je, Gracias und Dankeschön, – Phil

Leave a comment

What Happens When Germany Has One Million Cannabis Patients? (804,687,322 pounds?) – by Bill Griffin / Marijuanatimes.org


Germany – the EU’s most populous state with 82 million people – is about to offer cannabis on medical insurance. When that happens, demand will soar.

Germany’s lower house of parliament passed a bill legalizing the production, sale and use of medical marijuana on January 19th, 2017.

The bill is restricted to the sale and use of cannabis to patients, and there is no provision for home growing. This means that all cannabis (sold legally) in Germany will come via a doctor’s prescription and from a pharmacy – just like any other prescription drug.

This ensures that the cannabis distributed is of a consistent quality and, most importantly, a consistent strength. It doesn’t ensure that it is especially interesting for cannabis connoisseurs or recreational users in terms of look, taste, smell or effects.

But thanks to the German bill, cannabis will be available through health insurance plans, which is a good thing as currently what is available in the pharmacy is a lot more expensive than what you can buy on the streets.

“Those who are severely ill need to get the best possible treatment and that includes health insurance funds paying for cannabis as a medicine for those who are chronically ill if they can’t be effectively treated any other way,” said Health Minister Hermann Groehe to Reuters.

Beginning last year, Germany has been distributing cannabis flowers through pharmacies on a case per case basis. This created a sizeable market of a few thousand patients that – due to the fact that Germany does not currently allow the cultivation of cannabis – is met through imports from (legal) cannabis producing countries, such as the Netherlands and Canada.

This is going to change. Companies are already rapidly putting together blueprints and applications to legally cultivate cannabis in Germany. Some of these companies are already importing and building up their distribution contacts and networks. As soon as they have the green light to cultivate, they will be building local facilities to meet the increasing demand.

Just how big this demand will be is currently based on estimates. Germany is a cannabis-friendly country, with 23.1% of the adult population having consumed cannabis. That’s nearly 19 million people, which given cannabis’ illegality at the time of the survey will include both medical and recreational users. To put things in perspective, Germany’s population is more than double that of California, with 82 million versus 39 million inhabitants.

Let’s say a conservative estimate of people enrolled on Germany’s medical cannabis programme will be a cool one million.

If an average patient consumes 1 gram per day – which is low or high, depending on your ailment – that would mean each patient would require 365 grams per year. Multiply that by a million and we are talking 365 metric tons – or 804,687,322 pounds. That’s a lot of pot and it’s going to take a lot of cultivation space to produce.

Who’s going to grow it?

As there is no entrance into the market for home growers or caregivers like in many U.S. states, this is going to have to be produced by companies running facilities with good agricultural practice (GAP), good distribution practice (GDP) and good manufacturing processes (GMP). You don’t get to distribute any drug in a pharmacy without such high quality control – especially in Germany.

As you can imagine, this is creating a feeding frenzy for big actors in the cannabis industry. In April, they will be convening in Berlin for the first European-based International Cannabis Business Conference. Local players with cultivation licenses will be seeking capital to meet the exacting requirements that only Germany can define. International money men will be homing in on those that can give them a great return on investment in this soon-to-be exceedingly lucrative market.

The result will be that patients in Germany will have safe access to cannabis-related medicines.

Every time a patient visits the pharmacy, they know that what they are going to get will be more or less the same as what they had the previous time. Their cannabis will be grown without human intervention in automated cultivation rooms. Biological engineers will be monitoring the grow installation and laboratories will test the end product to ensure that the cannabinoid profiles will remain consistent from batch to batch.

Once complete, the buds will be irradiated of soil microorganisms and they will be packaged and stored in perfect conditions until it is handed to the patient in a white paper bag and a smile from their local pharmacist.

All cannabis culture has been methodically stripped out of the cannabis that will be distributed.

As a hobby home grower and recreational user – self-medicating in the absence of legislation that will allow me to get a prescription – I find this a rather sad ending to the calls for legalisation from millions of Europeans over the last 50 years. I have to admit, for many patients getting true medicinal grade cannabis free from pests, diseases or any adulterants is a good thing; growing cannabis to this level of consistency at home is virtually impossible. I’m not discounting it for recreational use, but in the way we class “medicine” in modern society it is not something that we produce in our homes – that’s called a “remedy”. Collectively and with empirical data to back it up we have agreed that medicine should be sterile. Cannabis from your greenhouse is far from sterile.

This arrangement will line the pockets of big investors and local entrepreneurs, but will also provide safe medicine to those who need it most. People who would never dream of growing their own or sourcing through a network of growers will be able to benefit from a medicine that has no adverse side effects.

The genie will be well and truly out of the bottle. More people in society will come to accept cannabis and see that the negative propaganda of the past was based on lies.

Increased cultivation, distribution and monitoring of patients will provide data that will have positive results. Science will finally be able to study cannabis, cannabinoids, terpenes and all the other components that make up the cannabis plant. This will lead to more breakthroughs and medical applications.

Germany is the largest population in Europe, and once they show that this can work, other countries will inevitably follow their lead.

However, for many activists this is not the end game; cannabis through pharmacies is just phase one. Ultimately, Germany will legalize cannabis for recreational use. That’s how it works, just look at the pattern in the U.S. and Canada. First, you legalize for medical use, then you decriminalize for recreational use, then you get full on legal cannabis to anyone who is old enough to buy it.

When that day comes there won’t just be one million medical patients; the full 23.1% of the German population that tried it will be able to consume without the guilt or anxiety that prohibition creates. This demand could only be met from decentralised local producers. This is where the connoisseurs will benefit. I dream of the day when, instead of dropping in my local wine shop, I stop by my local cannabis dispensary to see what delights they have on offer. It’s some way off at the moment, but my money’s on this becoming a reality in the not-too-distant future.